Algorithm-based Drug Discovery
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
76
NCT06215755
A Study of VRG50635 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 15, 2024
Completion: Jun 30, 2026
NCT06286475
A Study of VRG50635 in Healthy Volunteers
Start: Feb 29, 2024
Completion: Apr 8, 2024
Loading map...